Vijaypd Ceutical Limited IPO
Vijaypd Ceutical Limited, originally established in 1971, is a leading distributor and supplier in the pharmaceutical and consumer goods sectors. The company was converted into a public limited company in 2024 and now provides a broad range of healthcare products across India. It is involved in the distribution of medicines, wellness products, and FMCG items to both B2B and B2C customers.
Business Operations
Vijaypd Ceutical Limited operates in the pharmaceutical distribution industry, offering a comprehensive portfolio of products including injections, tablets, capsules, ointments, suppositories, vitamins, hormones, wellness tonics, serums, diagnostic kits, and more. The company also provides personal care products, ayurvedic items, cosmetics, and food products. With a customer base spanning over 2,100 pharmacies, clinics, and nursing homes, the company delivers products across Mumbai, Ratnagiri, Aurangabad, and Akola.
Manufacturing and Logistics
The company maintains three distribution warehouses across Mumbai, ensuring timely delivery to its customers. Its logistics operations are supported by a strong last-mile delivery infrastructure and a direct connection with over 170 healthcare product manufacturers, providing access to over 19,000 SKUs. The company uses advanced technology for inventory management and has a robust system for managing cold-chain logistics, ensuring the safety and quality of sensitive pharmaceutical products.
Expansion Plans
The company is looking to expand its operations further by diversifying into the manufacturing of Active Pharmaceutical Ingredients (APIs) and excipients. This move is aimed at enhancing the company’s ability to provide high-quality raw materials for pharmaceutical formulations and improve the stability and bioavailability of drug formulations.
Competitive Strengths
i) Strong Customer Relationships: Vijaypd Ceutical Limited has long-standing relationships with its clients, ensuring a steady revenue stream.
ii) Comprehensive Product Portfolio: The company offers a wide range of products across various pharmaceutical and consumer goods sectors.
iii) Experienced Management Team: The leadership team’s expertise in the pharmaceutical industry has been critical in the company’s growth and success.
iv) Efficient Supply Chain Management: With streamlined logistics and inventory management systems, the company delivers products in a timely and cost-efficient manner.
Objects of the Vijaypd Ceutical Limited IPO:
Vijaypd Ceutical Limited IPO Details:
| Open Date: | Sep 29 2025 |
| Close Date: | Oct 01 2025 |
| Total Shares: | 55,00,000 |
| Face Value: | ₹ 10 Per Equity Share |
| Issue Type: | Fixed Price |
| Issue Size: | 19.25 Cr. |
| Lot Size: | 4000 Shares |
| Issue Price: | ₹ 35 Per Equity Share |
| Listing At: | NSE Emerge |
| Listing Date: | Oct 07 2025 |
Promoters And Management:
Financials of Vijaypd Ceutical Limited IPO:
| Particulars | FY 2024-25 | FY 2023-2024 ] | FY 2022-2023 ' |
| Revenue from Operations (Cr) | 106.81 | 54.32 | 48.76 |
| EBITDA (Cr) | 8.59 | 4.86 | 1.31 |
| EBITDA Margins | 8.04% | 8.96% | 2.70% |
| PAT (Cr) | 4.79 | 1.65 | 0.18 |
| PAT Margins | 4.49% | 3.04% | 0.37% |
| ROCE | 17.30% | 14.61% | 8.90% |
| Debt to Equity Ratio(In Times) | 0.68 | 30.03 | 5.18 |
| Operating Cash Flows (Cr) | -7.88 | 2.92 | 0.3 |
Comparison With Peers:
| Companies | Revenue (in cr) | EBITDA Margins | PAT Margins | ROCE | D/E Ratio | MCap (in cr) | P/E |
| Vijaypd Ceutical Limited | 106.81 | 8.04% | 4.49% | 17.30% | 0.68 | 68.35 | 14.27 |
| MedPlus Health Services Limited | 6136 | 8% | 2.44% | 10.30% | 0.64 | 9,061 | 53.8 |
| Entero Healthcare Solutions Limited | 5096 | 3% | 2.10% | 8.71% | 0.22 | 4,802 | 46.9 |
Lead Manager of Vijaypd Ceutical Limited IPO:
Registrar of Vijaypd Ceutical Limited IPO:
Discussion on Vijaypd Ceutical Limited IPO:
Leave a Reply
You must be logged in to post a comment.